KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) FCF Payout Ratio (2016 - 2025)

Historic FCF Payout Ratio for Gilead Sciences (GILD) over the last 12 years, with Q3 2025 value amounting to 0.25.

  • Gilead Sciences' FCF Payout Ratio rose 716.46% to 0.25 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.43, marking a year-over-year increase of 510.42%. This contributed to the annual value of 0.38 for FY2024, which is 2602.28% down from last year.
  • As of Q3 2025, Gilead Sciences' FCF Payout Ratio stood at 0.25, which was up 716.46% from 1.38 recorded in Q2 2025.
  • Gilead Sciences' FCF Payout Ratio's 5-year high stood at 1.38 during Q2 2025, with a 5-year trough of 0.23 in Q3 2024.
  • For the 5-year period, Gilead Sciences' FCF Payout Ratio averaged around 0.5, with its median value being 0.43 (2023).
  • Over the last 5 years, Gilead Sciences' FCF Payout Ratio had its largest YoY gain of 8864.61% in 2024, and its largest YoY loss of 5983.39% in 2024.
  • Over the past 5 years, Gilead Sciences' FCF Payout Ratio (Quarter) stood at 0.3 in 2021, then surged by 31.18% to 0.39 in 2022, then grew by 24.74% to 0.49 in 2023, then decreased by 29.08% to 0.34 in 2024, then decreased by 26.99% to 0.25 in 2025.
  • Its FCF Payout Ratio was 0.25 in Q3 2025, compared to 1.38 in Q2 2025 and 0.61 in Q1 2025.